Zilovertamab vedotin
Patritumab deruxtecan
Disitamab vedotin
Cofetuzumab pelidotin
Farletuzumab ecteribulin
Sofituzumab vedotin
Labetuzumab govitecan
Cantuzumab mertansine
Cantuzumab ravtansine
Azintuxizumab vedotin
Tusamitamab ravtansine
Trastuzumab duocarmazine
Loncastuximab tesirine
Trastuzumab emtansine
Trastuzumab emtansine (solution)
Brentuximab vedotin (solution)
Enfortumab vedotin-ejfv
Enfortumab vedotin-ejfv (solution)
Belantamab mafodotin
Ifinatamab deruxtecan